Clinical Trial Update: A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants and Participants With Chronic Kidney Disease and Type 2 Diabetes and to Assess Home Measurements of Creatinine in a Non Interventional Cohort [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of AZD4248 in healthy participants and in individuals with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• AZD4248 (AZD4248)

Snippet

Sponsor: AstraZeneca | Conditions: Chronic Kidney Disease | Phase 1 | Status: RECRUITING